1. High Tide entered the German medical cannabis market successfully in 2025. 2. The company reported an annualized revenue run-rate of $600 million. 3. Canna Cabana expanded to 218 locations, with over 2.4 million Cabana Club members. 4. Strong same-store sales growth of 7.4% highlights operational strength. 5. Recognized as a top growing company for five consecutive years.
FAQ
Why Bullish?
High Tide's strong revenue growth and international expansion are fundamentally positive. Historical examples such as Canopy Growth's expansion strategies align with stock performance improvement.
How important is it?
The milestones achieved position HITI favorably in the growing cannabis market, enhancing investor confidence.
Why Long Term?
The expansion into international markets, particularly Germany, supports sustained growth potential, similar to other successful cannabis companies.
High Tide Inc. (HITI) Achieves Significant Milestones in 2025
High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leader in the cannabis retail sector, announced substantial achievements throughout 2025. This year marked a pivotal moment for High Tide as the Company expanded its footprint and solidified its market position, highlighted by surpassing 200 stores and amassing over 2 million Canadian Cabana Club members.
Transformational Year for High Tide
According to Raj Grover, the Founder and CEO of High Tide, "2025 was a truly transformational year for High Tide as we evolved from a domestic market leader into a global cannabis company." The Company successfully maintained a positive cash flow while demonstrating robust growth, a rare feat in the retail sector.
Since its establishment in 2018, High Tide has transformed from a single-store operation to a prominent cannabis brand with over 200 Canna Cabana locations. This growth reflects the Company’s operational excellence and strategic focus.
Financial Achievements and Market Expansion
In 2025, High Tide generated over $2 billion in cumulative sales since Canada legalized cannabis. The Company’s successful entry into the German medical cannabis market through the acquisition of a majority stake in Remexian Pharma GmbH stands out as a key milestone, positioning High Tide among the largest importers and distributors of medical cannabis in Germany.
Key financial highlights include:
- Annualized revenue run-rate of $600 million prior to contributions from Remexian.
- Annualized Adjusted EBITDA run-rate of over $42 million.
- Retail sales per square foot reached $1,735 across the Canna Cabana store network.
- Increase of 7.4% in same-store sales year-over-year during the third fiscal quarter of 2025.
- Surpassed 2.4 million Cabana Club members, including 139,000 ELITE members.
- Maintained a 12% market share across five Canadian provinces.
- Opened 27 new Canna Cabana locations, aligning with their goal of 20-30 new locations.
Looking Ahead: Strategic Objectives
High Tide is not resting on its laurels. As Mr. Grover states, "Our focus remains on further strengthening our brand, expanding our global footprint, and delivering long-term value for shareholders." The Company continues to cultivate its product portfolio, with 21 unique Queen of Bud cannabis SKUs and 29 accessory SKUs available in-store.
High Tide's ongoing dedication to growth has earned it recognition as one of Canada's Top Growing Companies by the Globe and Mail's Report on Business for the fifth consecutive year, underscoring its commitment to operational excellence.
About High Tide Inc.
High Tide, Inc. is a community-focused, retail-centric cannabis enterprise designed to unlock the potential of the cannabis sector. Through its wholly owned subsidiary, Canna Cabana, the Company is the largest cannabis retail chain in Canada, boasting 218 locations and a growing market share. In 2025, High Tide became the first North American cannabis operator to establish a physical presence in Germany, further solidifying its international ambitions.
The Company’s diverse operations encompass retail, medical cannabis distribution through Remexian Pharma GmbH, and multiple e-commerce platforms. To explore more about High Tide's impact in the cannabis industry, visit www.hightideinc.com.